Contact this trialFirst, we need to learn more about you.
Behavioural Intervention
AVP-786 for Agitation in Alzheimer's Disease
Recruiting1 awardPhase 3
Houston, Texas
This trial tests AVP-786, an oral medication taken regularly, in people with Alzheimer's disease who have significant agitation. The goal is to see if it can reduce their agitation and improve their behavior.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service